fda warning letters glp-1 october 2025 Issues Against Online Sellers Drug ad enforcement ramps up–again

Van Laer, K., Oliveira, M., Wahni, K

Although not FDA-approved as weight loss medications, both Mounjaro and Ozempic have demonstrated significant weight loss effects in clinical trials

doi: 10.1007/s11356-018-1629-7

Other cosmetic advantages may also be evaluated, including improvements in skin elasticity and wrinkles, to obtain more comprehensive results and information regarding the effects of glutathione

Novo and Lilly have asked the FDA to bar compounders from using their active ingredients and filed lawsuits against compounders and related manufacturers

When conventional wisdom is bypassed, many unexpected positive outcomes often emerge